These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

748 related articles for article (PubMed ID: 16497728)

  • 21. Hyperresponsiveness of vitamin D receptor gene expression to 1,25-dihydroxyvitamin D3. A new characteristic of genetic hypercalciuric stone-forming rats.
    Yao J; Kathpalia P; Bushinsky DA; Favus MJ
    J Clin Invest; 1998 May; 101(10):2223-32. PubMed ID: 9593778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of 1alpha,25-dihydroxyvitamin D3 on the expression of DNA replication genes.
    Eelen G; Verlinden L; van Camp M; van Hummelen P; Marchal K; de Moor B; Mathieu C; Carmeliet G; Bouillon R; Verstuyf A
    J Bone Miner Res; 2004 Jan; 19(1):133-46. PubMed ID: 14753745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of 1,25-dihydroxyvitamin D3-dependent transcription by synthetic LXXLL peptide antagonists that target the activation domains of the vitamin D and retinoid X receptors.
    Pathrose P; Barmina O; Chang CY; McDonnell DP; Shevde NK; Pike JW
    J Bone Miner Res; 2002 Dec; 17(12):2196-205. PubMed ID: 12469913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An enhancer 20 kilobases upstream of the human receptor activator of nuclear factor-kappaB ligand gene mediates dominant activation by 1,25-dihydroxyvitamin D3.
    Nerenz RD; Martowicz ML; Pike JW
    Mol Endocrinol; 2008 May; 22(5):1044-56. PubMed ID: 18202151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
    Verlinden L; Verstuyf A; Quack M; Van Camp M; Van Etten E; De Clercq P; Vandewalle M; Carlberg C; Bouillon R
    J Bone Miner Res; 2001 Apr; 16(4):625-38. PubMed ID: 11315990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor.
    Dunlop TW; Väisänen S; Frank C; Molnár F; Sinkkonen L; Carlberg C
    J Mol Biol; 2005 Jun; 349(2):248-60. PubMed ID: 15890193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of Enhancer-mediated Hormonal Control of Vitamin D Receptor Gene Expression in Target Cells.
    Lee SM; Meyer MB; Benkusky NA; O'Brien CA; Pike JW
    J Biol Chem; 2015 Dec; 290(51):30573-86. PubMed ID: 26504088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA sequences in the rat parathyroid hormone-related peptide gene responsible for 1,25-dihydroxyvitamin D3-mediated transcriptional repression.
    Falzon M
    Mol Endocrinol; 1996 Jun; 10(6):672-81. PubMed ID: 8776727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel mutation in the deoxyribonucleic acid-binding domain of the vitamin D receptor causes hereditary 1,25-dihydroxyvitamin D-resistant rickets.
    Lin NU; Malloy PJ; Sakati N; al-Ashwal A; Feldman D
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2564-9. PubMed ID: 8675579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin-like growth factor binding protein-5 interacts with the vitamin D receptor and modulates the vitamin D response in osteoblasts.
    Schedlich LJ; Muthukaruppan A; O'Han MK; Baxter RC
    Mol Endocrinol; 2007 Oct; 21(10):2378-90. PubMed ID: 17595320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor.
    Saramäki A; Banwell CM; Campbell MJ; Carlberg C
    Nucleic Acids Res; 2006; 34(2):543-54. PubMed ID: 16434701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deletion of the Distal Tnfsf11 RL-D2 Enhancer That Contributes to PTH-Mediated RANKL Expression in Osteoblast Lineage Cells Results in a High Bone Mass Phenotype in Mice.
    Onal M; St John HC; Danielson AL; Pike JW
    J Bone Miner Res; 2016 Feb; 31(2):416-29. PubMed ID: 26332516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 1,25-dihydroxyvitamin D3 down-regulation of PHEX gene expression is mediated by apparent repression of a 110 kDa transfactor that binds to a polyadenine element in the promoter.
    Hines ER; Kolek OI; Jones MD; Serey SH; Sirjani NB; Kiela PR; Jurutka PW; Haussler MR; Collins JF; Ghishan FK
    J Biol Chem; 2004 Nov; 279(45):46406-14. PubMed ID: 15337762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of mouse Cyp24a1 expression via promoter-proximal and downstream-distal enhancers highlights new concepts of 1,25-dihydroxyvitamin D(3) action.
    Pike JW; Meyer MB
    Arch Biochem Biophys; 2012 Jul; 523(1):2-8. PubMed ID: 22179019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The 1,25(OH)2D3-regulated transcription factor MN1 stimulates vitamin D receptor-mediated transcription and inhibits osteoblastic cell proliferation.
    Sutton AL; Zhang X; Ellison TI; Macdonald PN
    Mol Endocrinol; 2005 Sep; 19(9):2234-44. PubMed ID: 15890672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of the murine renal vitamin D receptor by 1,25-dihydroxyvitamin D3 and calcium.
    Healy KD; Zella JB; Prahl JM; DeLuca HF
    Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9733-7. PubMed ID: 12900504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perspectives on mechanisms of gene regulation by 1,25-dihydroxyvitamin D3 and its receptor.
    Pike JW; Meyer MB; Watanuki M; Kim S; Zella LA; Fretz JA; Yamazaki M; Shevde NK
    J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):389-95. PubMed ID: 17223545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human and murine osteocalcin gene expression: conserved tissue restricted expression and divergent responses to 1,25-dihydroxyvitamin D3 in vivo.
    Sims NA; White CP; Sunn KL; Thomas GP; Drummond ML; Morrison NA; Eisman JA; Gardiner EM
    Mol Endocrinol; 1997 Oct; 11(11):1695-708. PubMed ID: 9328351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene.
    D'Ambrosio D; Cippitelli M; Cocciolo MG; Mazzeo D; Di Lucia P; Lang R; Sinigaglia F; Panina-Bordignon P
    J Clin Invest; 1998 Jan; 101(1):252-62. PubMed ID: 9421488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes.
    Wang TT; Tavera-Mendoza LE; Laperriere D; Libby E; MacLeod NB; Nagai Y; Bourdeau V; Konstorum A; Lallemant B; Zhang R; Mader S; White JH
    Mol Endocrinol; 2005 Nov; 19(11):2685-95. PubMed ID: 16002434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.